CD90/Thy‐1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias*
- 8 March 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 125 (2), 203-212
- https://doi.org/10.1111/j.1365-2141.2004.04883.x
Abstract
Different transformation mechanisms have been proposed for elderly acute myeloid leukaemia (AML) and secondary AML (sAML) when compared with de novo AML or AML of younger patients. However, little is known regarding differences in the immunophenotypic profile of blast cells in these diseases. We systematically analysed, by flow cytometry, 148 patients affected by de novo (100 cases) or sAML (48 cases). By defining a cut-off level of 20% of CD34+ cells co-expressing CD90, the frequency of CD90+ cases was higher in sAML (40%) versus de novo AML (6%, P < 0.001), elderly AML (>60 years) (24%) versus AML of younger patients (10%, P = 0.010) and poor- versus good-risk karyotypes (according to the Medical Research Council classification, P < 0.001). The correlation between CD90 expression, sAML and unfavourable karyotypes was confirmed by analysing the subset of CD34+ AML cases alone (91/148). Consistently, univariate analysis showed that expression of CD90 was statistically relevant in predicting a shorter survival in CD90+ AML patients (P = 0.042). Our results, demonstrating CD90 expression in AML with unfavourable clinical and biological features, suggest an origin of these diseases from a CD90-expressing haemopoietic progenitor and indicate the use of CD90 as an additional marker of prognostic value in AML.Keywords
This publication has 48 references indexed in Scilit:
- Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)Blood, 2003
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patientsBritish Journal of Haematology, 2001
- Is Myelodysplastic Related Acute Myelogenous Leukemia a Distinct Entity from de novo Acute Myelogenous Leukemia? Potential for Targeted TherapiesLeukemia & Lymphoma, 2001
- Normalizing Complementary DNA by Quantitative Reverse Transcriptase–Polymerase Chain Reaction of β2-Microglobulin: Molecular Monitoring of Minimal Residual Disease in Acute Promyelocytic LeukemiaDiagnostic Molecular Pathology, 2000
- Expression of Thy-1 on human hematopoietic progenitor cells.The Journal of Experimental Medicine, 1993
- Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow.The Journal of Experimental Medicine, 1990
- Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoproteinNature, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958